<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/537E6E74-A70D-4A33-8D56-01A794B2BC6A"><gtr:id>537E6E74-A70D-4A33-8D56-01A794B2BC6A</gtr:id><gtr:firstName>Niall</gtr:firstName><gtr:otherNames>Patrick</gtr:otherNames><gtr:surname>Quinn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A47BB0A4-29B1-46AB-A0A8-0F7497EE8E5D"><gtr:id>A47BB0A4-29B1-46AB-A0A8-0F7497EE8E5D</gtr:id><gtr:firstName>Keith</gtr:firstName><gtr:surname>Wheatley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/306A8430-E50F-4936-A550-4562112FF4E0"><gtr:id>306A8430-E50F-4936-A550-4562112FF4E0</gtr:id><gtr:firstName>Thelekat</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Varma</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7B916DF8-A198-4331-AB09-A5B5C216B0F7"><gtr:id>7B916DF8-A198-4331-AB09-A5B5C216B0F7</gtr:id><gtr:firstName>Crispin</gtr:firstName><gtr:surname>Jenkinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5BE9A65A-E828-47DF-ACC8-6EDCD8F108A6"><gtr:id>5BE9A65A-E828-47DF-ACC8-6EDCD8F108A6</gtr:id><gtr:firstName>Adrian</gtr:firstName><gtr:surname>Williams</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7807E7B0-0709-4728-B283-5B83F76D0B5D"><gtr:id>7807E7B0-0709-4728-B283-5B83F76D0B5D</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:surname>Gill</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9900797"><gtr:id>040EBB46-5012-45FC-A5AD-7656CA766836</gtr:id><gtr:title>A large randomised long-term assessment of the relative effectiveness of surgery for Parkinson's disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9900797</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Surgery for Parkinson?s disease may be performed at three sites (thalamus, globus pallidum or subthalamic nucleus (STN)) using two techniques (electrical stimulation or radio frequency lesioning). There is very little reliable evidence available as to the optimal timing, site and technique. Few randomised trials have addressed these questions, and those that have been performed have been small. Most published reports relate to small non-randomised series, which can not provide reliable evidence because of the potential selection biases involved. Although surgery may produce rapid and obvious clinical improvements, it is important to evaluate the safety and long-term effects of the procedure. There is, therefore, an urgent need for large randomised trials of surgery for PD to be undertaken.

PDSURG is a randomised controlled trial that will evaluate the role of STN surgery, by either stimulation or lesioning, compared to medical therapy (with surgical intervention delayed as long as possible) in patients with advanced PD that is not controlled by their current medical treatment. Patients allocated to medical therapy will receive whatever drug treatment is considered appropriate (this may include continuous apomorphine infusion). 

PDSURG is a large, simple, real-life trial. It will accrue 400 to 600 patients, and will follow them for up to 9 years, in order to obtain reliable evidence on the long-term risks and benefits of surgery. The majority of assessments will be by questionnaires to patients (and their carers) to evaluate quality of life, with some clinical evaluations in a subset of patients. An economic analysis will be a major component of the trial.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1370450</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Health and Wellbeing</gtr:department><gtr:description>HE anslyses for PD SURG</gtr:description><gtr:id>29A5A353-E6F2-42BA-938A-4F487054D055</gtr:id><gtr:impact>First publication in preparation</gtr:impact><gtr:outcomeId>oLpdbzKv663-1</gtr:outcomeId><gtr:partnerContribution>Emma McIntosh has performed the Health Economic Modelling of the PD SURG data to examine the cost-effectiveness of Deep Brain Stimulation versus medical therapy alone.</gtr:partnerContribution><gtr:piContribution>BCTU collects all the trial data, send out queries and requests for more data where neccessary. Sections of the data, per the grant application, are anonymised and sent to collaborators who are expert in different aspects of their analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Oxford Health Services Research Unit</gtr:department><gtr:description>PDQ-39 and SF-36 analyses PD SURG</gtr:description><gtr:id>A274D7BA-6FD9-4403-8DB9-74D3A93541D8</gtr:id><gtr:impact>See abstracts submitted by C. Jenkinson</gtr:impact><gtr:outcomeId>JZu7LPn2jm6-1</gtr:outcomeId><gtr:partnerContribution>undertake analyses of PD-SURG quality of life and outcomes data. In particular:
1. Explore the relationship between the Parkinson Disease Questionaire (PDQ-39) and the UPDRS clinical rating scale
2. Evaluate the relationship between patient quality of life as reported on the PDQ-39 and carer reported strain/quality of life using both cross sectional and longitudinal data.
3. Evaluate the data gained from the PDQ-39 using Rasch analyses and determine the extent to which the measure assesses unidimensional constructs.</gtr:partnerContribution><gtr:piContribution>BCTU collects all the trial data, send out queries and requests for more data where neccessary. Sections of the data, per the grant application, are anonymised and sent to collaborators who are expert in different aspects of their analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>BBC news</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>2931DC44-4260-4447-B02D-3A4FFE47D971</gtr:id><gtr:impact>Lots of feed-back from patients

Invitations to patient groups</gtr:impact><gtr:outcomeId>jZZ2C9iEuhF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Patient Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BCB0FD9E-2157-4A13-A715-71D7A9704F17</gtr:id><gtr:impact>Participants in our clinical trials receive newsletters updating them on the progress of our research. The newsletters are also available on our websites.

Newsletters often spark requests for more information, most typically about our DNA bank. We have also started to include articles written by participants which has generated a lot of interest and responses from other participants.</gtr:impact><gtr:outcomeId>GGaDDL2332Y</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at Parkinson's UK meeting</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B2EF2176-D6EE-4BD5-8A1A-044C28FD6760</gtr:id><gtr:impact>Parkinson's UK holds meetings every 2 years for researchers and patients/public to discuss updates in research in to PD.

Discussions with colleagues have lead to a meeting to look at the possibility of a new clinical trial.</gtr:impact><gtr:outcomeId>hPzZ5v4pUkw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2010,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3712</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Network of Hubs for Trials Methodology Research (HTMR)</gtr:department><gtr:description>Medical Research Council Midland Hub for Trials Methodology Research</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0800808</gtr:fundingRef><gtr:id>426AC40D-3881-44C5-B041-A89938875CB9</gtr:id><gtr:outcomeId>BgdJUpAZENj</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210060</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Emma MacIntosh - Senior Research Fellowship</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>60DD51BB-FAE1-4A38-865F-A5D5DAFF8791</gtr:id><gtr:outcomeId>LzXDcVHjsdu0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>discussions with health authorities</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>60A2D7AE-1FE4-471D-AA73-314C29E3DE74</gtr:id><gtr:impact>Work in Progress</gtr:impact><gtr:outcomeId>TGvCp78ceDf</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DC5AFFF4-54F9-4F8C-8868-0C3327CFE5AC</gtr:id><gtr:title>PARKINSON'S DISEASE QUESTIONNAIRE (PDQ-39) AS A PRIMARY ENDPOINT IN A TRIAL COMPARING DEEP BRAIN STIMULATION WITH BEST MEDICAL THERAPY VERSUS BEST MEDICAL THERAPY ALONE FOR ADVANCED PARKINSON'S DISEASE (PD SURG TRIAL): A RANDOMISED, OPEN-LABEL TRIAL</gtr:title><gtr:parentPublicationTitle>VALUE IN HEALTH</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e45ff49b1a710704c60ee1d0585d41a"><gtr:id>8e45ff49b1a710704c60ee1d0585d41a</gtr:id><gtr:otherNames>Jenkinson C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1098-3015</gtr:issn><gtr:outcomeId>LnjEBPByWRm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50C1D1DA-7C54-429B-AAB3-5C1B02EEC5CE</gtr:id><gtr:title>The impact of surgery in Parkinson's disease on carer quality of life: Results from the PD SURG trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2892e8ef8afac9b641378c7a5ca6205"><gtr:id>c2892e8ef8afac9b641378c7a5ca6205</gtr:id><gtr:otherNames>Patel S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>deainvYorLJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EE44A53-459C-4C9E-B60B-C5E58AD68C7E</gtr:id><gtr:title>Patient quality of life impacts on carer quality of life in advanced Parkinson's disease - results from the PD SURG trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8c9a904735f1a4275250f7a5a8bc660"><gtr:id>d8c9a904735f1a4275250f7a5a8bc660</gtr:id><gtr:otherNames>Rick C. E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>ML7QcyzAgPr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD6E450-BB19-4892-B388-950C0FC62F82</gtr:id><gtr:title>Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/66ef18d27aaab3e2eb29829908cf1ed4"><gtr:id>66ef18d27aaab3e2eb29829908cf1ed4</gtr:id><gtr:otherNames>Williams A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>SkbAhjYAsPn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F858CEB-5FD4-41EF-A84E-4C9BF623C687</gtr:id><gtr:title>The Use of Apomorphine in the PD SURG Trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/23f1a47920deab633d5c448b24c6fae2"><gtr:id>23f1a47920deab633d5c448b24c6fae2</gtr:id><gtr:otherNames>Rick C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>ZXkKJkFhkTy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF2C2A4A-5196-4729-967C-5E07EE98F925</gtr:id><gtr:title>Does STIMULUS predict the best candidates for deep brain stimulation for PD?</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8c9a904735f1a4275250f7a5a8bc660"><gtr:id>d8c9a904735f1a4275250f7a5a8bc660</gtr:id><gtr:otherNames>Rick C. E.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>MKiCvHDdJBS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>485EE081-C30F-4AAD-BEAC-B8E6218938D7</gtr:id><gtr:title>Which patients with Parkinson's disease benefit most from surgery? Subgroup analysis from the PD SURG trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2892e8ef8afac9b641378c7a5ca6205"><gtr:id>c2892e8ef8afac9b641378c7a5ca6205</gtr:id><gtr:otherNames>Patel S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>go23FADS1Za</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C462432-AA51-4681-A34F-0937BF2DC67A</gtr:id><gtr:title>Implantable pulse generator lifespan in the PD SURG trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e1517623ae45367a29639064450a5b0"><gtr:id>8e1517623ae45367a29639064450a5b0</gtr:id><gtr:otherNames>Ottridge R. S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>EE8YJdFxwU4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>195AB894-29CD-4087-B38F-2BE18EEA4FE9</gtr:id><gtr:title>PD SURG: A large, randomised trial to assess the impact of surgery in Parkinson's disease (PD)</gtr:title><gtr:parentPublicationTitle>ANNALS OF NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e79fead8cf51c538226e7f67d482a96"><gtr:id>3e79fead8cf51c538226e7f67d482a96</gtr:id><gtr:otherNames>Williams Adrian</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>CYBFb9kYwet</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AE0F836-9922-4753-9855-7D20E8640F8C</gtr:id><gtr:title>Induction of parkinsonian resting tremor by stimulation of the caudal zona incerta nucleus: a clinical study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0e4f8b44682ad74ae3590cdc506a37"><gtr:id>7d0e4f8b44682ad74ae3590cdc506a37</gtr:id><gtr:otherNames>Plaha P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_16284_14_18037629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C6AC91E-B07D-434C-A05F-E1200C257E22</gtr:id><gtr:title>Correlation of patient quality of life and a clinical rating scale in advanced Parkinson's disease (PD) - results from the PD SURG trial</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8489d8da41dcb5a97ce7dd587d1245e3"><gtr:id>8489d8da41dcb5a97ce7dd587d1245e3</gtr:id><gtr:otherNames>Mistry S.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>Rnkx37VUjuD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E82F725-D930-433E-AF26-660B38A3AE65</gtr:id><gtr:title>Bilateral stimulation of the caudal zona incerta nucleus for tremor control.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0e4f8b44682ad74ae3590cdc506a37"><gtr:id>7d0e4f8b44682ad74ae3590cdc506a37</gtr:id><gtr:otherNames>Plaha P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_16284_14_18037630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A315955-70C0-45E4-90D4-5518BA4C5342</gtr:id><gtr:title>Benefits and Risks of Deep Brain Stimulation for People with Parkionson's Disease (PD SURG Collaborative Group)</gtr:title><gtr:parentPublicationTitle>NEUROLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bbfc472526d781a646290494b136d119"><gtr:id>bbfc472526d781a646290494b136d119</gtr:id><gtr:otherNames>Wheatley Keith</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>G8H8ERRzFzi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD5E4A5E-A53B-409F-9A75-D5899C3CB546</gtr:id><gtr:title>PD SURG: A large, randomised trial to assess the impact of surgery in Parkinson's disease</gtr:title><gtr:parentPublicationTitle>MOVEMENT DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451056c92d0d46c25c1186a95e18ff46"><gtr:id>451056c92d0d46c25c1186a95e18ff46</gtr:id><gtr:otherNames>Williams A.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>jj3R6y4fwPb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BEF7CE4-D0EB-4CBF-AB27-25193041B502</gtr:id><gtr:title>Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d0e4f8b44682ad74ae3590cdc506a37"><gtr:id>7d0e4f8b44682ad74ae3590cdc506a37</gtr:id><gtr:otherNames>Plaha P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_16284_24_21285454</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9900797</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>046212FE-8853-46F0-B1E7-3CBA4770A15F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.4  Surgery</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>